About Cambridge Biomedical
Cambridge Biomedical is a company based in Boston (United States) founded in 1997 was acquired by BioAgilytix in November 2019.. Cambridge Biomedical operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Cellply and Nordic Bioscience, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
BioAgilytix
(Nov 04, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cambridge Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cambridge Biomedical
Cambridge Biomedical has secured backing from 1 investor. Prominent investors backing the company include BioAgilytix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cambridge Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cambridge Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cambridge Biomedical Comparisons
Competitors of Cambridge Biomedical
Cambridge Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Cellply and Nordic Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| domain | founded_year | HQ Location |
Bioanalytical assays for drug development are developed and validated.
|
|
| domain | founded_year | HQ Location |
Analytical and quality assurance services are provided for diverse industries.
|
|
| domain | founded_year | HQ Location |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| domain | founded_year | HQ Location |
Integrated R&D services are provided for pharmaceuticals and allied sectors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cambridge Biomedical
When was Cambridge Biomedical founded?
Cambridge Biomedical was founded in 1997.
Where is Cambridge Biomedical located?
Cambridge Biomedical is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
What does Cambridge Biomedical do?
Founded in 1997 and based in Boston, United States, Cambridge Biomedical operates as a contract research organization and diagnostic laboratory. Bioanalytical services are specialized in, including custom assay development, validation, optimization, and biosimilar assays. Clinical diagnostics are offered through reference laboratory testing, alongside biomarker, companion diagnostics, and cell-based assays. Support is extended across drug development stages, from preclinical to phase IV trials and post-market testing.
Who are the top competitors of Cambridge Biomedical?
Cambridge Biomedical's top competitors include Alderley Analytical, BioAgilytix and CytoTronics.
Who are Cambridge Biomedical's investors?
Cambridge Biomedical has 1 investor. Key investors include BioAgilytix.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.